Opinion|Videos|January 5, 2026

Strategies for Early Detection in Alzheimer Disease

Panelists discuss how proactive screening and education empower APPs to detect Alzheimer disease earlier and initiate timely intervention.

Panelists discuss how earlier identification of cognitive impairment is essential to effective Alzheimer management. They stress the value of integrating screening tools in primary care visits, especially for aging populations, and of training advanced practice providers (APPs) to recognize subtle behavioral or cognitive changes that may indicate early disease.

Panelists discuss how systematic approaches—such as annual wellness assessments and standardized cognitive testing—can streamline referrals and prevent diagnostic delays. Collaboration between APPs and physicians is highlighted as a way to close gaps in patient awareness and follow-through, ensuring that early symptoms trigger timely evaluation.

Panelists discuss how public and professional education play a crucial role in overcoming stigma and encouraging earlier medical attention. By fostering proactive screening within community networks, APPs contribute to reducing the number of patients who present at advanced stages when fewer treatment options are available.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo